Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin

Microbiology

Volumn 158, Issue 1, 2012, Pages 240-258

  Stie, Jamal ^a   Fox, Deborah ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; MATRIGEL; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR;

ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; CELL INVASION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENCAPSULATION; ENZYME ACTIVITY; FUNGAL VIABILITY; FUNGAL VIRULENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE;

ANIMALS; BACTERIAL ADHESION; BLOOD-BRAIN BARRIER; CATTLE; CELLS, CULTURED; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENDOTHELIAL CELLS; FIBRINOLYSIN; HUMANS; PLASMINOGEN; PROTEIN BINDING; VIRULENCE;

FILOBASIDIELLA NEOFORMANS;

EID: 84855239367     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.051524-0     Document Type: Article

References (96)

1. Ambesi, A., Klein, R. M., Pumiglia, K. M. & McKeown-Longo, P. J. (2005). Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G1 arrest in human microvessel endothelial cells. Cancer Res 65, 148-156
2. Attali, C., Durmort, C., Vernet, T. & Di Guilmi, A. M. (2008). The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect Immun 76, 5350-5356
3. Bennett, J. E., Kwon-Chung, K. J. & Howard, D. H. (1977). Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 105, 582-586
4. Bergmann, S. & Hammerschmidt, S. (2007). Fibrinolysis and host response in bacterial infections. Thromb Haemost 98, 512-520
5. Bolaños, B. & Mitchell, T. G. (1989). Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum. J Leukoc Biol 46, 521-528
6. Brooks, A. M., Bates, M. E., Vrtis, R. F., Jarjour, N. N., Bertics, P. J. & Sedgwick, J. B. (2006). Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma. Am J Respir Cell Mol Biol 35, 503-511
7. Chang, Y. C. & Kwon-Chung, K. J. (1994). Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14, 4912-4919
8. Chang, Y. C., Stins, M. F., McCaffery, M. J., Miller, G. F., Pare, D. R., Dam, T., Paul-Satyaseel, M., Kim, K. S. & Kwon-Chung, K. J. (2004). Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 72, 4985-4995
9. Charlier, C., Chrétien, F., Baudrimont, M., Mordelet, E., Lortholary, O. & Dromer, F. (2005). Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166, 421-432
10. Charlier, C., Nielsen, K., Daou, S., Brigitte, M., Chretien, F. & Dromer, F. (2009). Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77, 120-127
11. Chauhan, S., Bisoi, A. K., Rao, B. H., Rao, M. S., Saxena, N. & Venugopal, P. (2000). Dosage of epsilon-aminocaproic acid to reduce postoperative blood loss. Asian Cardiovasc Thorac Ann 8, 15-18
12. Chen, L. C., Blank, E. S. & Casadevall, A. (1996). Extracellular proteinase activity of Cryptococcus neoformans. Clin Diagn Lab Immunol 3, 570-574
13. Chen, S. C., Muller, M., Zhou, J. Z., Wright, L. C. & Sorrell, T. C. (1997). Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis 175, 414-420
14. Chen, S. H., Stins, M. F., Huang, S. H., Chen, Y. H., Kwon-Chung, K. J., Chang, Y., Kim, K. S., Suzuki, K. & Jong, A. Y. (2003). Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 52, 961-970
15. Cole, J. N., McArthur, J. D., McKay, F. C., Sanderson-Smith, M. L., Cork, A. J., Ranson, M., Rohde, M., Itzek, A., Sun, H. & other authors (2006). Trigger for group A streptococcal M1T1 invasive disease. FASEB J 20, 1745-1747
16. Coleman, J. L., Gebbia, J. A., Piesman, J., Degen, J. L., Bugge, T. H. & Benach, J. L. (1997). Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89, 1111-1119
17. Cork, A. J., Jergic, S., Hammerschmidt, S., Kobe, B., Pancholi, V., Benesch, J. L., Robinson, C. V., Dixon, N. E., Aquilina, J. A. & Walker, M. J. (2009). Defining the structural basis of human plasminogen binding by streptococcal surface enolase. J Biol Chem 284, 17129-17137
18. Crowe, J. D., Sievwright, I. K., Auld, G. C., Moore, N. R., Gow, N. A. & Booth, N. A. (2003). Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins. Mol Microbiol 47, 1637-1651
19. D'Souza, C. A., Hagen, F., Boekhout, T., Cox, G. M. & Heitman, J. (2004). Investigation of the basis of virulence in serotype A strains of Cryptococcus neoformans from apparently immunocompetent individuals. Curr Genet 46, 92-102
20. Del Rosso, M., Fibbi, G., Pucci, M., Margheri, F. & Serrati, S. (2008). The plasminogen activation system in inflammation. Front Biosci 13, 4667-4686
21. Dong, Z. M. & Murphy, J. W. (1995). Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect Immun 63, 2632-2644
22. Ellis, V. (2003). Plasminogen activation at the cell surface. Curr Top Dev Biol 54, 263-312
23. Foster, A. J., Bird, R. A., Kelly, S. L., Nishimura, K., Poyner, D., Taylor, S. & Smith, S. N. (2004). FITC-lectin avidity of Cryptococcus neoformans cell wall and capsular components. Mycologia 96, 1-8
24. Fox, D. & Smulian, A. G. (2001). Plasminogen-binding activity of enolase in the opportunistic pathogen Pneumocystis carinii. Med Mycol 39, 495-507
25. Franzot, S. P., Mukherjee, J., Cherniak, R., Chen, L. C., Hamdan, J. S. & Casadevall, A. (1998). Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66, 89-97
26. Franzot, S. P., Salkin, I. F. & Casadevall, A. (1999). Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 37, 838-840
27. Gebbia, J. A., Monco, J. C., Degen, J. L., Bugge, T. H. & Benach, J. L. (1999). The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J Clin Invest 103, 81-87
28. Goguen, J. D., Bugge, T. & Degen, J. L. (2000). Role of the pleiotropic effects of plasminogen deficiency in infection experiments with plasminogen-deficient mice. Methods 21, 179-183
29. Goldman, D., Lee, S. C. & Casadevall, A. (1994). Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 62, 4755-4761
30. Granger, D. L., Perfect, J. R. & Durack, D. T. (1985). Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest 76, 508-516
31. Guimarães, A. H., Laurens, N., Weijers, E. M., Koolwijk, P., van Hinsbergh, V. W. & Rijken, D. C. (2007). TAFI and pancreatic carboxypeptidase B modulate in vitro capillary tube formation by human microvascular endothelial cells. Arterioscler Thromb Vasc Biol 27, 2157-2162
32. Hajjar, K. A., Jacovina, A. T. & Chacko, J. (1994). An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269, 21191-21197
33. Hancock, K. & Tsang, V. C. (1983). India ink staining of proteins on nitrocellulose paper. Anal Biochem 133, 157-162
34. Henkel, R. D., VandeBerg, J. L. & Walsh, R. A. (1988). A microassay for ATPase. Anal Biochem 169, 312-318
35. Ibrahim, A. S., Filler, S. G., Alcouloumre, M. S., Kozel, T. R., Edwards, J. E., Jr & Ghannoum, M. A. (1995a). Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule. Infect Immun 63, 4368-4374
36. Ibrahim, A. S., Mirbod, F., Filler, S. G., Banno, Y., Cole, G. T., Kitajima, Y., Edwards, J. E., Jr, Nozawa, Y. & Ghannoum, M. A. (1995b). Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 63, 1993-1998
37. Idnurm, A., Bahn, Y. S., Nielsen, K., Lin, X., Fraser, J. A. & Heitman, J. (2005). Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat Rev Microbiol 3, 753-764
38. Jong, A. Y., Chen, S. H., Stins, M. F., Kim, K. S., Tuan, T. L. & Huang, S. H. (2003). Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells. J Med Microbiol 52, 615-622
39. Jong, A., Wu, C. H., Chen, H. M., Luo, F., Kwon-Chung, K. J., Chang, Y. C., Lamunyon, C. W., Plaas, A. & Huang, S. H. (2007). Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot Cell 6, 1486-1496
40. Jong, A., Wu, C. H., Prasadarao, N. V., Kwon-Chung, K. J., Chang, Y. C., Ouyang, Y., Shackleford, G. M. & Huang, S. H. (2008a). Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-a activation. Cell Microbiol 10, 1854-1865
41. Jong, A., Wu, C. H., Shackleford, G. M., Kwon-Chung, K. J., Chang, Y. C., Chen, H. M., Ouyang, Y. & Huang, S. H. (2008b). Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol 10, 1313-1326
42. Kim, K. S. (2008). Mechanisms of microbial traversal of the bloodbrain barrier. Nat Rev Microbiol 6, 625-634
43. Kovacs, J. A., Kovacs, A. A., Polis, M., Wright, W. C., Gill, V. J., Tuazon, C. U., Gelmann, E. P., Lane, H. C., Longfield, R. & other authors (1985). Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 103, 533-538
44. Kozel, T. R. & Gotschlich, E. C. (1982). The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 129, 1675-1680
45. Kukkonen, M., Suomalainen, M., Kyllönen, P., Lähteenmäki, K., Lång, H., Virkola, R., Helander, I. M., Holst, O. & Korhonen, T. K. (2004). Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella enterica. Mol Microbiol 51, 215-225
46. Kwon-Chung, K. (1992). Cryptococcosis. In Medical Mycology, pp. 397-446. Edited by K. Kwon-Chung & J. Bennett. Philadelphia: Lea & Febiger.
47. Kwon-Chung, K. J. & Bennett, J. E. (1984). Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 120, 123-130
48. Lähteenmäki, K., Kuusela, P. & Korhonen, T. K. (2001). Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 25, 531-552
49. Lathem, W. W., Price, P. A., Miller, V. L. & Goldman, W. E. (2007). A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 315, 509-513
50. Lee, S. C., Dickson, D. W. & Casadevall, A. (1996). Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol 27, 839-847
51. Leidich, S. D., Ibrahim, A. S., Fu, Y., Koul, A., Jessup, C., Vitullo, J., Fonzi, W., Mirbod, F., Nakashima, S. & other authors (1998). Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem 273, 26078-26086
52. Levitz, S. M. & DiBenedetto, D. J. (1989). Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol 142, 659-665
53. Lipovsky, M. M., Gekker, G., Hu, S., Ehrlich, L. C., Hoepelman, A. I. & Peterson, P. K. (1998). Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J Infect Dis 177, 260-263
54. Litvintseva, A. P. & Mitchell, T. G. (2009). Most environmental isolates of Cryptococcus neoformans var. grubii (serotype A) are not lethal for mice. Infect Immun 77, 3188-3195
55. Litvintseva, A. P., Thakur, R., Vilgalys, R. & Mitchell, T. G. (2006). Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics 172, 2223-2238
56. Loftus, B. J., Fung, E., Roncaglia, P., Rowley, D., Amedeo, P., Bruno, D., Vamathevan, J., Miranda, M., Anderson, I. J. & other authors (2005). The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 307, 1321-1324
57. Melchor, J. P. & Strickland, S. (2005). Tissue plasminogen activator in central nervous system physiology and pathology. Thromb Haemost 93, 655-660
58. Miles, L. A., Levin, E. G., Plescia, J., Collen, D. & Plow, E. F. (1988). Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cells. Blood 72, 628-635
59. Miles, L. A., Hawley, S. B., Baik, N., Andronicos, N. M., Castellino, F. J. & Parmer, R. J. (2005). Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front Biosci 10, 1754-1762
60. Monaco, S., Gioia, M., Rodriguez, J., Fasciglione, G. F., Di Pierro, D., Lupidi, G., Krippahl, L., Marini, S. & Coletta, M. (2007). Modulation of the proteolytic activity of matrix metalloproteinase-2 (gelatinase A) on fibrinogen. Biochem J 402, 503-513
61. Mukherjee, P. K. G. M. A. (2001). Secretory proteins in fungal virulence. In Fungal Pathogenesis-Principles and Clinical Applications. Edited by R. A. Calderone & R. L. Cihlar. New York: Marcel Dekker.
62. Naglik, J. R., Rodgers, C. A., Shirlaw, P. J., Dobbie, J. L., Fernandes-Naglik, L. L., Greenspan, D., Agabian, N. & Challacombe, S. J. (2003). Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J Infect Dis 188, 469-479
63. Nogueira, S. V., Fonseca, F. L., Rodrigues, M. L., Mundodi, V., Abi-Chacra, E. A., Winters, M. S., Alderete, J. F. & de Almeida Soares, C. M. (2010). Paracoccidioides brasiliensis enolase is a surface protein that binds plasminogen and mediates interaction of yeast forms with host cells. Infect Immun 78, 4040-4050
64. O'Meara, T. R., Norton, D., Price, M. S., Hay, C., Clements, M. F., Nichols, C. B. & Alspaugh, J. A. (2010). Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog 6, e1000776.
65. Olszewski, M. A., Noverr, M. C., Chen, G. H., Toews, G. B., Cox, G. M., Perfect, J. R. & Huffnagle, G. B. (2004). Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 164, 1761-1771
66. Pai, M. P., Sakoglu, U., Peterson, S. L., Lyons, C. R. & Sood, R. (2009). Characterization of BBB permeability in a preclinical model of cryptococcal meningoencephalitis using magnetic resonance imaging. J Cereb Blood Flow Metab 29, 545-553
67. Pancholi, V., Fontan, P. & Jin, H. (2003). Plasminogen-mediated group A streptococcal adherence to and pericellular invasion of human pharyngeal cells. Microb Pathog 35, 293-303
68. Pepper, M. S. (2001). Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21, 1104-1117
69. Pepper, M. S., Montesano, R., Mandriota, S. J., Orci, L. & Vassalli, J. D. (1996). Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49, 138-162
70. Plow, E. F., Felez, J. & Miles, L. A. (1991). Cellular regulation of fibrinolysis. Thromb Haemost 66, 32-36
71. Plow, E. F., Herren, T., Redlitz, A., Miles, L. A. & Hoover-Plow, J. L. (1995). The cell biology of the plasminogen system. FASEB J 9, 939-945
72. Potempa, J. & Pike, R. N. (2009). Corruption of innate immunity by bacterial proteases. J Innate Immun 1, 70-87
73. Quan, X. & Godfrey, H. P. (1998). In vitro study of cytokine-mediated activation of endothelial cell permeability using Falcon® cell culture inserts. Tech Bull 413, 1-3
74. Reese, A. J. & Doering, T. L. (2003). Cell wall α-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol Microbiol 50, 1401-1409
75. Reijerkerk, A., Mosnier, L. O., Kranenburg, O., Bouma, B. N., Carmeliet, P., Drixler, T., Meijers, J. C., Voest, E. E. & Gebbink, M. F. (2003). Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system. Mol Cancer Res 1, 561-568
76. Rodrigues, M. L., Nimrichter, L., Oliveira, D. L., Frases, S., Miranda, K., Zaragoza, O., Alvarez, M., Nakouzi, A., Feldmesser, M. & Casadevall, A. (2007). Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell 6, 48-59
77. Romer, J., Bugge, T. H., Fyke, C., Lund, L. R., Flick, M. J., Degen, J. L. & Dano, K. (1996). Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2, 287-292
78. Schatteman, G. C., Dunnwald, M. & Jiao, C. (2007). Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol 292, H1-H18.
79. Sebbane, F., Jarrett, C. O., Gardner, D., Long, D. & Hinnebusch, B. J. (2006). Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci U S A 103, 5526-5530
80. Shi, M., Li, S. S., Zheng, C., Jones, G. J., Kim, K. S., Zhou, H., Kubes, P. & Mody, C. H. (2010). Real-time imaging of trapping and ureasedependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest 120, 1683-1693
81. Sodeinde, O. A., Subrahmanyam, Y. V., Stark, K., Quan, T., Bao, Y. & Goguen, J. D. (1992). A surface protease and the invasive character of plague. Science 258, 1004-1007
82. Stie, J., Bruni, G. & Fox, D. (2009). Surface-associated plasminogen binding of Cryptococcus neoformans promotes extracellular matrix invasion. PLoS ONE 4, e5780.
83. Sun, H., Ringdahl, U., Homeister, J. W., Fay, W. P., Engleberg, N. C., Yang, A. Y., Rozek, L. S., Wang, X., Sjöbring, U. & Ginsburg, D. (2004). Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305, 1283-1286
84. Tkachuk, V. A., Plekhanova, O. S. & Parfyonova, Y. V. (2009). Regulation of arterial remodeling and angiogenesis by urokinasetype plasminogen activator. Can J Physiol Pharmacol 87, 231-251
85. Tuma, P. L. & Hubbard, A. L. (2003). Transcytosis: crossing cellular barriers. Physiol Rev 83, 871-932
86. Vecchiarelli, A., Retini, C., Monari, C., Tascini, C., Bistoni, F. & Kozel, T. R. (1996). Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 64, 2846-2849
87. Velagapudi, R., Hsueh, Y. P., Geunes-Boyer, S., Wright, J. R. & Heitman, J. (2009). Spores as infectious propagules of Cryptococcus neoformans. Infect Immun 77, 4345-4355
88. Verstraete, M. (1985). Clinical application of inhibitors of fibrinolysis. Drugs 29, 236-261
89. Vidotto, V., Melhem, M., Pukinskas, S., Aoki, S., Carrara, C. & Pugliese, A. (2005). Extracellular enzymatic activity and serotype of Cryptococcus neoformans strains isolated from AIDS patients in Brazil. Rev Iberoam Micol 22, 29-33
90. Vidotto, V., Ito-Kuwa, S., Nakamura, K., Aoki, S., Melhem, M., Fukushima, K. & Bollo, E. (2006). Extracellular enzymatic activities in Cryptococcus neoformans strains isolated from AIDS patients in different countries. Rev Iberoam Micol 23, 216-220
91. Whittington, A. & Wang, P. (2011). The RGS protein Crg2 is required for establishment and progression of murine pulmonary cryptococcosis. Med Mycol 49, 263-275
92. Wolff, E. C., Schirmer, E. W. & Folk, J. E. (1962). The kinetics of carboxypeptidase B activity. J Biol Chem 237, 3094-3099
93. Wong, V. L. & Gumbiner, B. M. (1997). A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136, 399-409
94. Zaas, A. K., Liao, G., Chien, J. W., Weinberg, C., Shore, D., Giles, S. S., Marr, K. A., Usuka, J., Burch, L. H. & other authors (2008). Plasminogen alleles influence susceptibility to invasive aspergillosis. PLoS Genet 4, e1000101.
95. Zaragoza, O. & Casadevall, A. (2004). Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6, 10-15
96. Zaragoza, O., Chrisman, C. J., Castelli, M. V., Frases, S., Cuenca-Estrella, M., Rodríguez-Tudela, J. L. & Casadevall, A. (2008). Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell Microbiol 10, 2043-2057.